BridgeBio Pharma is a biopharmaceutical company that develops and manufactures medicines. Its lobbying filings show it focuses on drug manufacturing and pricing rules, including issues around orphan drugs and implementing the Inflation Reduction Act (a federal law affecting drug rebates and pricing). It has also lobbied on Medicare/Medicaid, pharmacy matters, and tax and budget issues.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
HAZEN CLAY MARSHALL
The latest disclosures for this client.
MARSHALL & POPP, LLC
Q3MARSHALL & POPP, LLC
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
MARSHALL & POPP, LLC
MONICA POPP
MARSHALL & POPP, LLC
MARSHALL & POPP, LLC
Q1MARSHALL & POPP, LLC
Q4MARSHALL & POPP, LLC
Q3MARSHALL & POPP, LLC
Q2MARSHALL & POPP, LLC
RR